NCT05048615 2023-01-25
Low-dose Venetoclax and Azacitidine as Front-line Therapy in Newly Diagnosed AML
Hospital Universitario Dr. Jose E. Gonzalez
Phase 2 Completed
Hospital Universitario Dr. Jose E. Gonzalez
Hangzhou Cancer Hospital
University of California, San Francisco
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Ain Shams University
Johns Hopkins University
Stanford University